Global coagulation assays in patients with chronic kidney disease and their role in predicting thrombotic risk

Hui Yin Lim1, Brandon Lui2, Mark Tacey3

  • 1Northern Clinical Pathology, Thrombosis & Radiology (NECTAR) Research Group, Northern Pathology Victoria, Northern Health, Epping, VIC, Australia; Department of Medicine, University of Melbourne, Northern Health, Epping, VIC, Australia; Department of Medicine, University of Melbourne, Austin Health, Heidelberg, VIC, Australia; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.

Insights

Patients with chronic kidney disease (CKD) exhibit a hypercoagulable state, increasing thrombotic risk. Global coagulation assays identified key predictors like tissue factor pathway inhibitor (TFPI) for better risk assessment in CKD patients.

Area of Science:

  • Nephrology
  • Hematology
  • Cardiovascular Medicine

Background:

  • Cardiovascular diseases and thrombosis are leading causes of mortality in chronic kidney disease (CKD) patients.
  • Currently, effective biomarkers for predicting thrombotic risk in CKD are lacking.

Purpose of the Study:

  • To evaluate global coagulation assays in CKD patients.
  • To correlate coagulation biomarkers with clinical outcomes in CKD.

Main Methods:

  • Prospective observational study of 90 CKD patients (eGFR<30 mL/min/1.73m²).
  • Global coagulation assays performed: thromboelastography, calibrated automated thrombogram (CAT), overall hemostatic potential (OHP), and tissue factor pathway inhibitor (TFPI).

Main Results:

  • CKD patients showed hypercoagulable states compared to controls (increased thromboelastography amplitude, peak thrombin, OHP, and TFPI).
  • Peritoneal-dialysis patients exhibited more hypercoagulable parameters than hemodialysis patients.
  • Key predictors of thrombotic complications included dialysis, higher fibrinogen, reduced endogenous thrombin potential, elevated D-dimer, and increased TFPI.

Conclusions:

  • CKD confers a hypercoagulable state, increasing thrombotic risk.
  • Paradoxical association of reduced thrombin generation and raised TFPI with thrombotic risk suggests complex compensatory mechanisms.
  • Developed risk model outperformed existing scores for predicting clinical outcomes in dialysis patients.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
56
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
42
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
49
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
47
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
37
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
39